Cytek Biosciences Financial Overview
Cytek Biosciences's market cap is currently $600.96M. The company's EPS TTM is $0.004; its P/E ratio is -47.58; Cytek Biosciences is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
